FSLLRY-NH2 trifluoroacetate salt
SIGMA/SML0714 - ≥98% (HPLC)
CAS Number: 245329-02-6 (free base)
Empirical Formula (Hill Notation): C39H60N10O8 · xC2HF3O2
Molecular Weight: 796.96 (free base basis)
Linear Formula: C39H60N10O8 · xC2HF3O2
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to off-white |
| form | powder |
| InChI | 1S/C39H60N10O8/c1-22(2)17 |
| InChI key | KMSCNWHRNILNRJ-JNRWAQIZSA |
| Quality Level | 100 ![]() |
| shipped in | wet ice |
| SMILES string | N([C@@H](CO)C(=O)N[C@@H]( |
| storage temp. | −20°C |
| Amino Acid Sequence: | Phe-Ser-Leu-Leu-Arg-Tyr-N |
| Application: | FSLLRY-NH2 trifluoroacetate salt has been used as a protease-activated receptor 2 (PAR2) inhibitor to test its effects on urinary tract infections (UTIs) in a murine model. It has also been used to study the clinical itch datasets from phase 3 clinical trials for moderate-to-severe AD in atopic dermatitis (AD)-associated acute itch flare mice modelin rats. |
| Biochem/physiol Actions: | FSLLRY-NH2 is a peptide antagonist of the protease activated receptor 2 (PAR2). |
| Biochem/physiol Actions: | FSLLRY-NH2 is a peptide antagonist of the protease activated receptor 2 (PAR2). The peptide blocks agonist induced itching in rodent models. In cell based assays, the peptide inhibits agonist-induced cardiocyte remodeling, and production of cytokines by endothelial cells. |
| Biochem/physiol Actions: | The ability of FSLLRY-NH2 to decrease visceral hypersensitivity (VH) suggests that PAR2 is involved in the maintenance of VH. |
| Packaging: | 1 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |

